Literature DB >> 10852187

Association of prenatal phenobarbital and phenytoin exposure with small head size at birth and with learning problems.

A B Dessens1, P T Cohen-Kettenis, G J Mellenbergh, J G Koppe, N E van De Poll, K Boer.   

Abstract

UNLABELLED: Small head size has been observed in prenatally anticonvulsant-exposed neonates. In infancy, cognitive impairments were revealed. It is presently unknown whether these impairments are permanent or disappear after puberty. We studied the link between the prenatal influence of anticonvulsants on brain development and cognitive functioning in adulthood: a retrospective study on head size and a follow-up assessing cognitive capacities among adults who had been included in the retrospective study. The retrospective study comprised 172 exposed and 168 control neonates, matched with respect to age, sex and their mothers' age. Prenatally phenobarbital + phenytoin-exposed neonates had a significantly smaller occipitofrontal circumference (OFC) than prenatally phenobarbital-monotherapy-exposed and control neonates (mean difference of 0.7 cm). In the follow-up, no difference in cognitive functioning was found between the exposed and the control groups. Most of the prenatally anticonvulsant-exposed subjects had normal intellectual capacity. However, 12% of the exposed subjects versus 1% of the controls had persistent learning problems. In addition, more of the exposed subjects were mentally retarded. There was no clear relationship between learning problems and small OFC, maternal epilepsy or unfavourable family climate.
CONCLUSIONS: We conclude that the combination of phenobarbital + phenytoin affects the fetal OFC. The smaller OFC does not seem to be related to cognitive functioning in adulthood, but learning problems and mental retardation proved to be more prevalent among exposed subjects. Phenobarbital and phenytoin may therefore affect cognitive capacity but only in infants who are susceptible to this particular influence of the drugs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10852187     DOI: 10.1080/080352500750027808

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  21 in total

Review 1.  Developmental neuropathology of environmental agents.

Authors:  Lucio G Costa; Michael Aschner; Annabella Vitalone; Tore Syversen; Offie Porat Soldin
Journal:  Annu Rev Pharmacol Toxicol       Date:  2004       Impact factor: 13.820

2.  Neurodevelopmental liabilities of substance abuse.

Authors:  Tomas Palomo; Trevor Archer; Richard J Beninger; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2002-06       Impact factor: 3.911

3.  Gender-specific effect of Mthfr genotype and neonatal vigabatrin interaction on synaptic proteins in mouse cortex.

Authors:  Elinor Blumkin; Tamar Levav-Rabkin; Osnat Melamed; Dalia Galron; Hava M Golan
Journal:  Neuropsychopharmacology       Date:  2011-04-13       Impact factor: 7.853

4.  Treatment of traumatic brain injury in pediatrics.

Authors:  Andranik Madikians; Christopher C Giza
Journal:  Curr Treat Options Neurol       Date:  2009-11       Impact factor: 3.598

5.  The frequency of neonatal morbidity after exposure to antiepileptic drugs in utero: a retrospective population-based study.

Authors:  Silva Burja; Zlatka Rakovec-Felser; Milena Treiber; Dusanka Hajdinjak; Marijana Gajsek-Marchetti
Journal:  Wien Klin Wochenschr       Date:  2006       Impact factor: 1.704

6.  Antiepileptic drugs and apoptotic neurodegeneration in the developing brain.

Authors:  Petra Bittigau; Marco Sifringer; Kerstin Genz; Ellen Reith; Dana Pospischil; Suresh Govindarajalu; Mark Dzietko; Stefanie Pesditschek; Ingrid Mai; Krikor Dikranian; John W Olney; Chrysanthy Ikonomidou
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-04       Impact factor: 11.205

Review 7.  Cognitive abilities and behaviour of children exposed to antiepileptic drugs in utero.

Authors:  Rebecca L Bromley; Gus A Baker; Kimford J Meador
Journal:  Curr Opin Neurol       Date:  2009-04       Impact factor: 5.710

Review 8.  Long-term consequences after exposure to antiepileptic drugs in utero.

Authors:  Lisa Forsberg; Katarina Wide
Journal:  Ther Adv Drug Saf       Date:  2011-10

Review 9.  An Update on Maternal Use of Antiepileptic Medications in Pregnancy and Neurodevelopment Outcomes.

Authors:  Elizabeth E Gerard; Kimford J Meador
Journal:  J Pediatr Genet       Date:  2015-06

Review 10.  [Neurotoxicity of general anesthetics in childhood: does anesthesia leave its mark on premature babies, newborns and infants?].

Authors:  B Sinner; K Becke; K Engelhard
Journal:  Anaesthesist       Date:  2013-02       Impact factor: 1.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.